SANOFI-AVENTIS (EPA:SAN) | Finanzwire

Basculer en Français

10481	Companies
220801	Keywords
150135	Articles
116795	Press releases

Home
Companies
SANOFI-AVENTIS

PRESS RELEASE

published on 10/20/2025 at 07:00, 7 months 12 days ago

Press Release: Sanofi’s high-dose influenza vaccine demonstrates superior protection for older adults against hospitalization vs standard-dose
Sanofi's high-dose influenza vaccine Efluelda/Fluzone High-Dose shows superior protection for older adults by reducing hospitalizations. FLUNITY-HD study details robust evidence published in The Lancet

Older Adults Sanofi Influenza Vaccine FLUNITY-HD Study Hospitalizations
BRIEF

published on 10/17/2025 at 13:10, 7 months 15 days ago

Sanofi's Wayrilz recommended by CHMP for IPT

Sanofi CHMP BTK Inhibitor Wayrilz Immune Thrombocytopenia
PRESS RELEASE

published on 10/17/2025 at 13:05, 7 months 15 days ago

Press Release: Sanofi’s Wayrilz recommended for EU approval by the CHMP to treat immune thrombocytopenia
CHMP recommends Sanofi's Wayrilz for EU approval to treat immune thrombocytopenia, targeting disease root cause through multi-immune modulation. Positive phase 3 study results showcased rapid platelet response and symptom improvements

Sanofi CHMP Wayrilz Immune Thrombocytopenia Multi-immune Modulation
BRIEF

published on 10/17/2025 at 13:05, 7 months 15 days ago

Sanofi faces negative EU opinion on Rezurock

Europe Sanofi CHMP Rezurock CGVHD
PRESS RELEASE

published on 10/17/2025 at 13:00, 7 months 15 days ago

Press Release: Sanofi provides update on regulatory review in the EU for Rezurock to treat chronic graft-vs-host disease
Sanofi announces negative CHMP opinion on Rezurock for chronic graft-vs-host disease in the EU but plans to seek re-examination. Rezurock has shown efficacy in clinical studies

EU Sanofi CHMP Rezurock CGVHD
BRIEF

published on 10/08/2025 at 07:05, 7 months 24 days ago

AlphaMedixTM: Positive Phase 2 Results for the Treatment of GEP-NETs

Clinical Trial Phase 2 Innovative Therapy AlphaMedixTM TNE-GEP
BRIEF

published on 09/24/2025 at 07:10, 8 months 7 days ago

Sanofi invests $625 million to boost Sanofi Ventures

Innovation Digital Health Investment Sanofi Biotechnologies
BRIEF

published on 09/24/2025 at 07:05, 8 months 7 days ago

Sanofi Releases Q3 2025 Aide Mémoire

Investor Relations Sanofi Financial Modeling Results Announcement Q3 2025
PRESS RELEASE

published on 09/24/2025 at 07:05, 8 months 7 days ago

Press Release: Sanofi commits an additional $625 million to Sanofi Ventures to accelerate investment in biotech and digital health innovation
Sanofi commits $625 million to Sanofi Ventures to boost biotech and digital health investments. Focus on immunology, rare diseases, neurology, vaccines

Digital Health Investment Biotech Ventures Sanofi
PRESS RELEASE

published on 09/24/2025 at 07:00, 8 months 7 days ago

Press release: Availability of the Q3 2025 Aide mémoire
Sanofi announces availability of Q3 2025 Aide mémoire for financial modeling purposes. Document covers non-comparable items, foreign currency impact, and share count

Investors Sanofi Financial Modeling Aide Mémoire Q3 2025

Accesswire

Published on 06/01/2026 at 18:30, 44 minutes ago

Galaxy Ventures Inc. Enters into Definitive Agreement with TruSilver Metals Corp. to Complete Qualifying Transaction
Published on 06/01/2026 at 15:30, 3 hours 44 minutes ago

Karbon-X to Present at the Small Cap Growth Virtual Investor Conference June 4th
Published on 06/01/2026 at 14:30, 4 hours 44 minutes ago

Klondike Gold Announces Receipt of Funds from Gold Royalty Payments and Warrants Exercise
Published on 06/01/2026 at 14:00, 5 hours 14 minutes ago

Datametrex AI Announces Completion Of Hilco Global Patent Portfolio Qualification Review
Published on 06/01/2026 at 13:30, 5 hours 44 minutes ago

Eskay Mining Corp. announces First Targets in its 5,000 meter Drill Program on its Corey-Eskay Property in British Columbia's Golden Triangle

View all ACCESSWIRE

EQS Group

Published on 06/01/2026 at 19:00, 14 minutes ago

Armen Pogossian Represents Armenia at Forbes Under 30 Summit China, Empowering the Next Generation of Global Entrepreneurs
Published on 06/01/2026 at 17:50, 1 hour 24 minutes ago

Alta Group announcement on Voluntary Takeover Offers for Addiko Bank AG
Published on 06/01/2026 at 17:46, 1 hour 28 minutes ago

Key Figures 31.05.2026
Published on 06/01/2026 at 17:45, 1 hour 29 minutes ago

mobilezone completes acquisition of Apfelkiste.ch and retail branding specialist MAREIN
Published on 06/01/2026 at 17:35, 1 hour 39 minutes ago

ANUA NAMES KENDALL JENNER AS FIRST-EVER GLOBAL BRAND AMBASSADOR

Les Echos

Published on 06/01/2026 at 18:47, 27 minutes ago

Disclosure of transactions in own shares from May 25 to May 29, 2026
Published on 06/01/2026 at 18:00, 1 hour 14 minutes ago

Covivio - Information on total number of voting rights and share capital
Published on 06/01/2026 at 17:54, 1 hour 20 minutes ago

Reporting on share buyback transactions carried out on May 28, 2026
Published on 06/01/2026 at 17:54, 1 hour 20 minutes ago

TF1 - Monthly disclosure of the total number of shares and voting rights - May 2026
Published on 06/01/2026 at 17:45, 1 hour 29 minutes ago

ENGIE secures €1 billion export financing backed by Euler Hermes

View all LES ECHOS COMFI WIRE